Target intelligence / Profile preview

PUS1 antisense RNA 1 (PUS1-AS1)

Target
PUS1-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

PUS1 antisense RNA 1 (PUS1-AS1, also known as AC131009.1) is a long non-coding RNA transcribed from the strand opposite the PUS1 gene, which encodes pseudouridine synthase 1. PUS1-AS1 has not been characterized as a therapeutic target, receptor, transporter, or enzyme. Antisense RNAs generally regulate their counterpart sense genes through mechanisms such as RNA interference or translational regulation, but no publications or major databases currently describe a specific molecular function, disease role, or druggability for PUS1-AS1 in humans. The primary literature and major gene databases (HGNC, GeneCards, NCBI Gene) either list PUS1-AS1 as an antisense RNA or lack entries for this RNA entirely, indicating it is not an established target in clinical or basic research. Most functional and disease relevance is associated with the protein-coding gene PUS1, not with its antisense RNA. PUS1 itself is an RNA-modifying enzyme implicated in RNA pseudouridylation and certain cancer contexts, but PUS1-AS1 does not share these characteristics based on current knowledge.

Other names
AC131009.1
02

Biological functions

Possibly involved in post-transcriptional regulation of PUS1 gene expression (inferred by analogy with known antisense RNAs in other loci)Other (due to insufficient specific literature on PUS1-AS1)
03

Disease associations

Unknown (no published data currently link PUS1-AS1 to human disease; its canonical gene, PUS1, is implicated in cancer and mitochondrial myopathy, but this does not apply to the antisense RNA)

Beyond the preview

Go deeper on PUS1 antisense RNA 1 (PUS1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PUS1 antisense RNA 1 (PUS1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call